Page 185

Siddiqui MA, Lin FY, Trostel B, Israel E, Dwyer DM. 1989. Adverse events following DTP immunization in Maryland, 1987. Maryland Medical Journal 38:556-559.

Starko KM, Ray CG, Dominguez LB, Stromberg WL, Woodall DF. 1980. Reye's syndrome and salicylate use. Pediatrics 66:859-864.

Steinman L, Sriram S, Adelman NE, Zamvil S, McDevitt HO, Urich H. 1982. Murine model for pertussis vaccine encephalopathy: linkage to H-2. Nature 299:738-740.

Steinman L, Weiss A, Adelman N, Lim M, Zuniga R, Oehlert J, Hewlett E, Falkow S. 1985. Pertussis toxin is required for pertussis vaccine encephalopathy. Proceedings of the National Academy of Sciences 82:8733-8736.

Stewart GT. 1977. Vaccination against whooping-cough: efficacy versus risks. Lancet 1:234-237.

Still GF. 1902. The Coulstonian lectures on some abnormal physical conditions in children. Lancet 1:1008-1012, 1077-1082, 1163-1168.

Strauss AA, Lehtinen LE. 1947. Psychopathology and Education in the Brain-Injured Child. New York: Grune & Stratton.

Strom J. 1967. Further experience of reactions, especially of a cerebral nature, in conjunction with triple vaccination: a study based on vaccinations in Sweden, 1959-1965. British Medical Journal 4:320-323.

Suffredini AF, Fromm RE, Parker MM, Brenner M, Kovacs JA, Wesley RA, Parrillo JE. 1989a. The cardiovascular response of normal humans to the administration of endotoxin. New England Journal of Medicine 321:280-287.

Suffredini AF, Harpel PC, Parrillo JE. 1989b. Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects. New England Journal of Medicine 320:1165-1172.

Szatmari P, Tuff L, Finlayson AJ, Bartolucci G. 1990. Aspergers syndrome and autismneurocognitive aspects. Journal of the American Academy of Child and Adolescent Psychiatry 29:130-136.

Tada T, Okumura K, Ochia T, Iwasa S. 1972. Effect of lymphocytosis-promoting factor of Bordetella pertussis on the immune response. II. Adjuvant effect of the production of reaginic antibody in the rat. International Archives of Allergy 43:207-216.

Thorndike RL. 1963. The concepts of over- and under-achievement. New York: Bureau of Publications, Teachers College, Columbia University.

Tsairis P, Dick PJ, Mulder DW. 1972. Natural history of brachial plexus neuropathy. Archives of Neurology 27:109-117.

United States Office of Education. 1977. Assistance to states for education for handicapped children: procedures for evaluating specific learning disabilities. Federal Register 42:62082-62085.

Vellutino FR. 1978. Toward an understanding of dyslexia: psychological factors in specific reading disability. In: Benton AL, Pearl D, eds. Dyslexia: An Appraisal of Current Knowledge. New York: Oxford University Press.

Vellutino FR. 1979. Dyslexia: Theory and Research. Cambridge, MA: MIT Press.

Vellutino FR, Scanlon DM. 1987. Phonological awareness and reading ability—evidence from a longitudinal and experimental study. Merrill-Palmer Quarterly Journal of Developmental Psychology 33:321-363.

Volkmar FR, Cohen DJ. 1986. Pervasive developmental disorders. In: Cavenar JO, ed. Psychiatry, Vol. 2. Philadelphia: J.B. Lippincott Co.

Waldman RJ, Hall WN, McGee H, Van Amburg G. 1982. Aspirin as a risk factor in Reye's syndrome. Journal of the American Medical Association 247:3089-3094.

Wardlaw AC, Parton R. 1983. Pertussis vaccine. In: Easmon CSF, Jeljaszewicz J, eds. Medical Microbiology, Vol. 2. New York: Academic Press.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement